Showing results (531-540 of 587) with videos related to

Sort By:
Pageof 59
Nature Communications|February 3, 2016
Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillationChia-Ti Tsai, Chia-Shan Hsieh, Sheng-Nan Chang, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET databaseK R Reddy, J K Lim, A Kuo, et al.
Plos One|February 26, 2013
The association between heme oxygenase-1 gene promoter polymorphism and the outcomes of catheter ablation of atrial fibrillationYu-Feng Hu, Kun-Tai Lee, Hsueh-Hsiao Wang, et al.
Frontiers in Oncology|July 10, 2023
Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatmentPi-Yi Chang, Rheun-Chuan Lee, Po-Chin Liang, et al.
Gastroenterology|October 12, 2014
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantationMichael Charlton, Edward Gane, Michael P Manns, et al.
Lancet (London, England)|August 10, 2010
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trialPaul Y Kwo, Eric J Lawitz, Jonathan McCone, et al.
Hepatology (Baltimore, Md.)|April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionNancy Reau, Paul Y Kwo, Susan Rhee, et al.
Scientific Reports|November 30, 2017
Bacterial alterations in salivary microbiota and their association in oral cancerWei-Hsiang Lee, Hui-Mei Chen, Shun-Fa Yang, et al.
Acta Cardiologica Sinica|June 8, 2022
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of HypertensionTzung-Dau Wang, Chern-En Chiang, Ting-Hsing Chao, et al.
Journal of Viral Hepatitis|November 14, 2018
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysisSteven Flamm, David Mutimer, Armen Asatryan, et al.
Pageof 59